These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9121266)

  • 1. 2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy.
    Elliot B; Aromin I; Gold R; Flanigan T; Mileno M
    Lancet; 1997 Mar; 349(9055):850. PubMed ID: 9121266
    [No Abstract]   [Full Text] [Related]  

  • 2. Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy.
    De Luca A; Ammassari A; Cingolani A; Giancola ML; Antinori A
    AIDS; 1998 Oct; 12(14):1937-8. PubMed ID: 9792402
    [No Abstract]   [Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy.
    Cinque P; Casari S; Bertelli D
    N Engl J Med; 1998 Sep; 339(12):848-9. PubMed ID: 9750081
    [No Abstract]   [Full Text] [Related]  

  • 4. Remission of progressive multifocal leucoencephalopathy after antiretroviral therapy.
    Domingo P; Guardiola JM; Iranzo A; Margall N
    Lancet; 1997 May; 349(9064):1554-5. PubMed ID: 9167486
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.
    Gasnault J; Taoufik Y; Goujard C; Kousignian P; Abbed K; Boue F; Dussaix E; Delfraissy JF
    J Neurovirol; 1999 Aug; 5(4):421-9. PubMed ID: 10463864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of Mycobacterium avium complex bacteremia following highly active antiretroviral therapy.
    Hadad DJ; Lewi DS; Pignatari AC; Martins MC; Vitti Júnior W; Arbeit RD
    Clin Infect Dis; 1998 Mar; 26(3):758-9. PubMed ID: 9524856
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
    Hall CD; Dafni U; Simpson D; Clifford D; Wetherill PE; Cohen B; McArthur J; Hollander H; Yainnoutsos C; Major E; Millar L; Timpone J
    N Engl J Med; 1998 May; 338(19):1345-51. PubMed ID: 9571254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy.
    Mayo J; Collazos J; Martínez E
    AIDS; 1998 Sep; 12(13):1720-2. PubMed ID: 9764796
    [No Abstract]   [Full Text] [Related]  

  • 9. Remission of progressive multifocal leucoencephalopathy after antiretroviral therapy.
    Baldeweg T; Catalan J
    Lancet; 1997 May; 349(9064):1554-5. PubMed ID: 9167487
    [No Abstract]   [Full Text] [Related]  

  • 10. Progressive multifocal leukoencephalopathy regression with highly active antiretroviral therapy.
    Teófilo E; Gouveia J; Brotas V; da Costa P
    AIDS; 1998 Mar; 12(4):449. PubMed ID: 9520183
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
    Karras A; Rabian C; Zylberberg H; Hermine O; Duchatelle V; Durand F; Valla D; Viard JP
    AIDS; 1998 May; 12(7):827-9. PubMed ID: 9619823
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.
    Rockstroh JK; Theisen A; Kaiser R; Sauerbruch T; Spengler U
    AIDS; 1998 May; 12(7):829-30. PubMed ID: 9619824
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data in from first head-to-head protease inhibitor.
    AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961
    [No Abstract]   [Full Text] [Related]  

  • 15. Regression of progressive multifocal encephalopathy with highly active antiretroviral therapy.
    Baqi M; Kucharczyk W; Walmsley SL
    AIDS; 1997 Oct; 11(12):1526-7. PubMed ID: 9342080
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
    Clark NM; Dieng Sarr A; Sankalé JL; Kanki PJ; Kazanjian P; Winfield R; Markovitz DM
    AIDS; 1998 Dec; 12(18):2506-7. PubMed ID: 9875594
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mollusca contagiosa in HIV-infected children receiving optimal antiretroviral therapy].
    Horneff G; Wahn V
    Klin Padiatr; 2000; 212(2):83-4. PubMed ID: 10812559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor.
    Lisziewicz J; Jessen H; Finzi D; Siliciano RF; Lori F
    Lancet; 1998 Jul; 352(9123):199-200. PubMed ID: 9683211
    [No Abstract]   [Full Text] [Related]  

  • 19. Study shows three drugs better than two.
    AIDS Alert; 1997 Apr; 12(4):39. PubMed ID: 11364145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for HIV infection.
    Med Lett Drugs Ther; 1997 Dec; 39(1015):111-6. PubMed ID: 9402928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.